TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 33 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 1,200 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 1,200 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | +100.0% | 1,200 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 1,200 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 1,200 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -95.2% | 1,200 | -92.6% | 0.00% | -100.0% |
| Q1 2022 | $42,000 | -4.5% | 16,200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $44,000 | +1000.0% | 16,200 | +1250.0% | 0.00% | – |
| Q3 2021 | $4,000 | -42.9% | 1,200 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -22.2% | 1,200 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | +350.0% | 1,200 | +9.1% | 0.00% | – |
| Q4 2020 | $2,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $9,004,920 | 2.70% |
| Ikarian Capital, LLC | 2,765,530 | $5,226,851 | 1.19% |
| JOHNSON & JOHNSON | 84,003 | $158,766 | 0.05% |
| X-Square Capital, LLC | 17,743 | $34 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $489,215 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $859,791 | 0.01% |
| HoyleCohen, LLC | 13,000 | $24,570 | 0.00% |
| MGO ONE SEVEN LLC | 11,780 | $22,264 | 0.00% |
| Bank of New York Mellon Corp | 66,606 | $125,885 | 0.00% |
| Citadel Advisors | 24,700 | $46,683 | 0.00% |